Data and market exclusivity in pharmaceuticals
December 2016
Data exclusivity (regulatory data protection) and related market exclusivity are rights attaching to certain pharmaceutical products; additional to and independent of patent protection.
Paul England, Manja Epping and Edward Vickers of Taylor Wessing discuss the current scope and application of these commercially important rights in Taylor Wessing's latest webinar: Data and market exclusivity in pharmaceuticals.
If you have any questions on this article or would like to propose a subject to be addressed by Synapse please contact us.
Paul England
Paul is a senior associate and professional support lawyer in the Patents group based in our London office.
Latest topical issues
The CMA expands its focus to drug pricing
The UK backs the UPC and Unitary Patent